Skip to main content

Advertisement

Table 3 Functional state (body weight, sleep, mood, quality of life) and saliva concentrations of oxytocin and IL-1ß at baseline

From: Saliva molecular inflammatory profiling in female migraine patients responsive to adjunctive cervical non-invasive vagus nerve stimulation: the MOXY Study

Patient no BMI kg/m2 Migraine Type MIDAS score/grade BDI score PSQI score EQ-5D-5L Oxytocin saliva pg/ml IL-1ß saliva pg/ml
1 22 CM+ 93/IV 25 8 12 61.6 215
2 19 EM+ 13/III 2 2 6 27.5 195
3 23 EM− 92/IV 23 10 15 24.1 1000
4 27 EM− 39/IV 20 10 5 29.6 822
5 28 CM+ 73/IV 44 13 18 105.3 334
6 20 EM− 40/IV 12 10 8 20.6 194
7 24 EM+ 51/IV 7 9 9 16.3 168
8 22 EM− 2/I 9 10 7 41 261
9 28 EM+ 47/IV 6 13 7 120.7 1000
10 27 EM+ 16/III 12 7 11 16.9 272
11 24 EM+ 106/IV 10 19 14 44.2 730
12 19 EM− 17/III 0 4 8 22.7 262
  1. BDI Becks depression inventory, BMI body mass index, CM chronic migraine, EM episodic migraine, EQ-5D-5L EuroQol five-dimensional five level scale, f female, MIDAS Migraine Disability Assessment, PSQI Pittsburgh Sleep Quality Index